EYPT
Companies
NASDAQ
EyePoint Pharmaceuticals Inc.
Health Care
$8.42
+$0.97 (+13.02%)
Price Chart
Overview
About EYPT
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Market Cap
$474.0M
Volume
5.8M
Avg. Volume
6.2M
P/E Ratio
-2.1943464
Dividend Yield
0.00%
Employees
150.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.69
High Correlation
Volatility
High (0.97)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, EYPT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$474.0M
Volume5.8M
P/E Ratio-2.19
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025